Accelerating the hit-to-lead optimization of a SARS-CoV-2 Mpro inhibitor series by combining high throughput medicinal chemistry and computational simulations
Hazemann, J., Mac Sweeney, A., Lange, R., Bourquin, G., Ritz, D., Richard, S., Regeon, S., Czodrowski, P.To be published.